000 03265nam a2200397 c 4500
999 _c10512
_d10512
001 10512
003 ES-MaUEC
005 20210609174211.0
006 a||||fo|||| 00| 0
007 cr nn nnnaamaa
008 210217s2021 gw | s |||| 0|eng d
020 _a9783030659080
024 7 _a10.1007/978-3-030-65908-0
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_erda
_dES-MaUEC
050 4 _aRC845
_b.F56 2021 EB
245 0 0 _aDiseases of the Liver and Biliary Tree
_cedited by Annarosa Floreani
250 _aFirst edition 2021
264 1 _aCham
_bSpringer Nature
_c2021
300 _a1 recurso en línea (VIII, 293 páginas)
_b40 ilustraciones, 21 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
505 0 _aPart 1. Congenital biliary abnormalities: Biliary atresia. Congenital cystic lesion of the biliary tree. Biliary hamartomas -- Part 2. Genetic cholangiopathies: Alagille syndrome. Caroli disease. Liver disease in cystic fibrosis. Low-phospholipidic associated cholelithiasis (LPAC syndrome) -- Part 3. Autoimmune cholangiopathies: Primary Biliary Cholangitis. Primary sclerosing cholangitis. IgG4-related cholangitis. Overlap syndromes -- Part 4. Secondary cholangiopathies: Inflammatory cholangitis. Drug-induced cholangiopathies -- Part 5 Neoplasms of the biliary tree:Cholangiocarcinoma -- Part 6. Special topics: Pregnancy and diseases of the biliary tree. Transplant and diseases of the biliary tree.
520 3 _aThis book provides a comprehensive overview of the diagnosis and management of diseases of the biliary tree. Topics covered include: congenital biliary abnormalities, genetic cholangiopathies, autoimmune cholangiopathies, inflammatory and drug-related cholangiopathies, and cholangiocarcinoma. Given their particular importance (even for clinicians working with adults), pediatric conditions are also examined. In addition, a special section is devoted to pregnancy and diseases of the biliary tree, and to transplants and diseases of the biliary tree. Each chapter offers up-to-date information on the management of the diseases discussed. Moreover, the book addresses new treatments for autoimmune cholestatic liver diseases, reflecting the new therapeutic targets that have recently been discovered. Examples include farnesoid X receptor (FXR) and peroxisome proliferator-activated receptor (PPAR)-agonists, together with new drugs that affect the composition of bile flow. Given its scope, the book offers a valuable guide for a broad range of practitioners.
650 7 _2embne
_9169917
_aHígado
_xEnfermedades
700 1 _aFloreani, Annarosa
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9783030659073
776 0 8 _iPrinted edition:
_z9783030659097
776 0 8 _iPrinted edition:
_z9783030659103
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-65908-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
_n0
998 _db
_zSI